Skip to content

ALPHARM OÜ

Registry code (registrikood) 14923106Private limited company (Osaühing)VAT EE102241398Activity (EMTAK 47731): Ravimite jaemüükActive

Maardu linn, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€5.7M
▲ 13.5% vs 2024
Profit before tax (2025)
€17k
Employees, FTE (2025)
17
State taxes paid, last 4 quarters
€351k

Revenue, profit and employees, 2020–2025

€3.5M2020€5.1M2021€5.2M2022€4.7M2023€5.0M2024€5.7M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2020€3,494,337€31,502€33,721€33,72118
2021€5,053,212€50,880€55,522€89,24320
2022€5,196,572-€90,287-€85,640€3,60317
2023€4,735,251€445€3,374€6,97715
2024€4,995,469-€7,499-€3,403€3,57418
2025€5,668,693€14,477€17,109€20,68317

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2020€124,699€872,634€838,913—€33,721
2021€328,858€1,095,343€1,006,100—€89,243
2022€124,361€845,229€841,626—€3,603
2023€197,202€968,124€961,147—€6,977
2024€206,918€1,006,335€1,002,761—€3,574
2025€293,488€1,069,650€1,048,967—€20,683

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€86,508€66,617€1,601,46921
2022 Q2€73,030€60,036€1,477,34620
2022 Q3€59,604€61,327€1,346,64322
2022 Q4€64,096€58,912€1,402,71322
2023 Q1€68,970€56,966€1,286,88523
2023 Q2€57,681€51,433€1,257,35423
2023 Q3€67,413€62,707€1,247,25622
2023 Q4€62,997€56,094€1,359,54921
2024 Q1€96,870€57,854€1,427,36621
2024 Q2€69,030€56,272€1,363,51821
2024 Q3€70,976€67,664€1,257,11221
2024 Q4€71,131€64,787€1,450,08723
2025 Q1€91,706€70,563€1,501,62723
2025 Q2€91,889€73,471€1,551,89023
2025 Q3€86,471€75,748€1,501,04123
2025 Q4€81,245€68,501€1,539,66924
2026 Q1€99,077€69,248€1,706,95224
2026 Q2€87,909€70,443€1,499,88822
2026 Q3€83,129€73,673€1,556,50922

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), ALPHARM OÜ reported revenue of €5,668,693.

The company closed the 2025 financial year with a net profit of €17,109.

Revenue increased by 13.5% from €4,995,469 in 2024 to €5,668,693 in 2025.

Revenue grew at a compound annual rate of 10.2% between 2020 and 2025.

Equity accounted for 1.9% of total assets of €1,069,650 at the end of the 2025 reporting period.

With 17 full-time-equivalent employees in 2025, revenue per employee was €333,453.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, ALPHARM OÜ reported €6,303,018 in turnover.

EMTA recorded 22 employees for the quarter ending Q3 2026, compared with 17 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.